USPTO Rejects Claims of Two Helicos Patents in Ongoing IP Dispute with PacBio

The company also disclosed that its 2010 revenues were up 47 percent, but that it still required additional funds to stay afloat.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.